Company news
Diaceutics PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Change of Auditor
November 29, 2022
Sub-optimal testing impacts on cancer patients
November 1, 2022
Half-year Report
September 27, 2022
Multi-year contract with top five global pharma
June 13, 2022
New AI and ML Capabilities Enhance DXRX Platform
June 7, 2022
Share Options and PDMR Shareholdings
May 27, 2022
Contract Win
May 5, 2022
Conversion of Convertible Loan Notes & TVR
April 5, 2022
Notice of 2021 Full Year Results
March 22, 2022
Confirmation of Directorate Change
March 18, 2022
Approval by CMS for enhanced data access
March 16, 2022
Investor Presentation
February 21, 2022
Contract with leading life sciences company
February 14, 2022
Directorate Change
January 11, 2022
Test Signal Launch and Contract Wins
December 9, 2021
Purchase/Transfer of Shares and PDMR Shareholdings
September 28, 2021
Nominated as finalists for Health Tech Awards 2021
September 21, 2021
DXRX Platform Contract Win
September 13, 2021
Two new experts join the Diaceutics Advisory Panel
September 8, 2021
Notice of Investor Presentation
August 31, 2021
Trading Update
July 8, 2021
Issue of Share Options and PDMR Shareholdings
July 1, 2021
New Contract Wins
June 24, 2021
Capital Markets Day and KPI Update
June 16, 2021
Notice of Capital Markets Day
June 7, 2021
Presenting data on COVID impact on cancer at ASCO
June 4, 2021
Change of Adviser
May 21, 2021
LGC SeraCare Partnership
May 13, 2021
Sale of Shares and PDMR Shareholding
May 12, 2021
Sale of Shares and Director/PDMR Shareholding
May 4, 2021
Share Incentive Plan
April 30, 2021
Notice of AGM and posting of Annual Report
April 21, 2021
New Vice President of Operations in Asia
April 12, 2021
Transfer of Shares and Director/PDMR Shareholding
April 8, 2021
COVID-19 Testing Data licensing agreement
April 1, 2021
New lease agreement and related party transaction
March 30, 2021
New Vice President of Finance appointment
March 4, 2021
Quarterly media update
January 21, 2021
Trading update
January 11, 2021
Diaceutics Appoints Seasoned Business Leader Deborah Davis as Non-executive Chair
December 22, 2020
Diaceutics and Alva10 partnership to deliver value-based test reimbursement model for US payers, pharma and testing providers via DXRX platform
November 30, 2020
European international award win
November 17, 2020
Commercial launch of DXRX
October 28, 2020
Diaceutics Partners With Global EQA Providers to Implement Best-in-class Testing Standards
September 28, 2020
Diaceutics Unveils Expert Advisory Panel Powering its Industry-Changing Diagnostic Network DXRX
September 14, 2020
Second Price Monitoring Extn
September 7, 2020
New contract win for DXRX platform
July 22, 2020
Diaceutics Partners With Targos and HistoCyte Laboratories to Drive Global Diagnostic Testing Standardization
July 14, 2020
Price Monitoring Extension
July 6, 2020
Issue of Share Options
July 3, 2020
Calls
The 5 newest of 8 calls. Every call is listed under its year.
- Diaceutics (LSE:DXRX) Q4 2024 Earnings Call
May 13, 2025
Transcript - Diaceutics (LSE:DXRX) Q2 2024 Earnings Call
Sep 17, 2024
Transcript - Diaceutics (LSE:DXRX) — Full Year 2023 Results
May 21, 2024
Transcript - Diaceutics (LSE:DXRX) — Interim Results
Sep 26, 2023
Transcript - Diaceutics (LSE:DXRX) — FY22 Results
Apr 18, 2023
Transcript
Decks
The 5 newest of 11 decks. Every deck is listed under its year.
- Investor Presentation (February 2026)
Investor deck · 18 slides · February 2026
- Investor Presentation (December 2025)
Investor deck · 18 slides · December 2025
- Investor Presentation (October 2025)
Investor deck · 18 slides · October 2025
- Investor Presentation (August 2025)
Investor deck · 17 slides · August 2025
- Investor Presentation (May 2025)
Investor deck · 17 slides · May 2025